Original Research

Consensus Statement Supporting the Recommendation for Single-Fraction Palliative Radiotherapy for Uncomplicated, Painful Bone Metastases

Author and Disclosure Information

 

References

For this reason, the authors believe that it is in the best interest for veterans with terminal cancers and their providers to be aware of the shorter SFRT for effective, convenient pain relief. This treatment option is particularly relevant for patients with a poor performance status, patients already in hospice care, or patient who travel long distances.

Author disclosures
The authors report no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the authors and do not necessarily reflect those of
Federal Practitioner , Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Click here to read the digital edition.

Pages

Recommended Reading

Preventing Skeletal-Related Events
AVAHO
Link Found Between Agent Orange Exposure and Multiple Myeloma
AVAHO
Gauging the Use of Single Fraction Radiotherapy for Painful Bone Metastases: The Experience of a Single Veterans Administration Radiation Oncology Center
AVAHO
Pain Control in Patients With Bone Metastases
AVAHO
A Mysterious Massive Hemorrhage
AVAHO
Can Serum Free Light Chains Be Used for the Early Diagnosis of Monoclonal Immunoglobulin-Secreting B-Cell and Plasma-Cell Diseases? (FULL)
AVAHO
Daratumumab Effective in Combo Regimen
AVAHO
Study Points to Risk Factors for Lymphoma
AVAHO
Multiple Myeloma and Stroke: What’s the Risk?
AVAHO
The Long Legacy of Agent Orange
AVAHO